ABBV vs IRD · P/E 81, rev $61.16B vs rev $11.0M
AbbVie Inc (ABBV) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ABBV and IRD stock pages for the full models.
Not investment advice.